Advertisement

Topics

Companies Related to "Therapy With Bevacizumab (BEV), Doxorubicin, and Cyclophosphamide Followed by BEV, Docetaxel, and Capecitabine Before Surgery Followed by BEV Alone After Surgery for Women With Locally Advanced Breast Cancer" [Most Relevant Company Matches] - Page: 5 RSS

22:41 EST 20th November 2018 | BioPortfolio

Here are the most relevant search results for "Therapy With Bevacizumab (BEV), Doxorubicin, and Cyclophosphamide Followed by BEV, Docetaxel, and Capecitabine Before Surgery Followed by BEV Alone After Surgery for Women With Locally Advanced Breast Cancer" found in our extensive corporate database of over 50,000 company records.

Showing "Therapy With Bevacizumab Doxorubicin Cyclophosphamide Followed Docetaxel Capecitabine" Companies 101–125 of 1,100+

Probably Relevant

BTL Industries

BTL Industries Limited designs, manufactures and sells medical equipment for physical therapy, cardiology, and medical aesthetics. Headquartered in Prague, the Czech Republic, the Company is among the world’s five largest physical therapy manufacturers. For the past 18 years, BTL Industries supplies its products through distributors designated for ...


MOTION PT Group, Inc.

MOTION PT Group was formed in June 2015 through the combination of Brooklyn-based MetroSportsMed with Manhattan-based STAR Physical Therapy. Today, MOTION has over 200 employees. Headquartered in New York City with 13 locations, the company is a leading provider of comprehensive physical and occupational therapy services with locations in the New York Metr...

Voyager Therapeutics

Voyager Therapeutics is a gene therapy company developing life-changing treatments for fatal and debilitating diseases of the central nervous system (CNS). Voyager is committed to advancing the field of AAV (adeno-associated virus) gene therapy through innovation and investment in vector optimization and engineering, dosing techniques, as well as process d...


G-Zero Therapeutics

G-Zero Therapeutics, Inc., a privately held pharmaceutical company, founded in 2008 by Dr. Norman Sharpless, University of North Carolina at Chapel Hill, Dr. Kwok-Kin Wong, Harvard Medical School, and Dr. John Chant, is focused on the discovery and development of novel small molecules for use in biodefense applications and cancer therapy. These mole...

VirRx, Inc.

VirRx, Inc., is a biotechnology company with a primary interest in cancer gene therapy. Its broad mission is to develop genetically modified "smart bomb" adenoviruses for use in treating human cancers. Adenoviruses are ubiquitous, benign viruses that are one of the causes of the common cold.VirRx scientists are experts on human adenoviruses, including construction of human adenovirus vectors for c...

Oxford BioMedica plc

Oxford BioMedica (LSE:OXB) is a leading gene and cell therapy group focused on developing life changing treatments for serious diseases. Oxford BioMedica and its subsidiaries (the "Group") have built a sector leading lentiviral vector delivery platform (LentiVector®), which the Group leverages to develop in vivo and ex vivo products both in-house and wi...

Compact Particle Acceleration Corporation

Compact Particle Acceleration Corporation (CPAC) is an independent privately held corporation in the proton therapy system business. The company is developing a very compact proton therapy system powered by the dielectric-wall accelerator (DWA). For more information, visit www.CPAC.pro.

Amorcyte, Inc.

Amorcyte is a privately held biotechnology company developing cell therapy products to treat cardiovascular disease. Its lead product AMR-001, for the prevention of major adverse cardiac events following acute myocardial infarction (AMI), has completed Phase I clinical trials demonstrating feasibility, safety and biologic activity at a threshold dose. This is the first stem cell trial in AMI eve...

Enzymatic Therapy, Inc

Enzymatic Therapy, Inc. is renowned as the highest quality provider of therapeutic dosage natural medicines and nutritional supplements in the industry. We incorporate FDA pharmaceutical quality standards in all facets of our business. This includes raw material evaluation and supplier selection, laboratory analytics across the entire spectrum of quality, purity, potency and efficacy measures, Qua...

Incara Pharmaceuticals

Incara Pharmaceuticals Corporation focuses on the protection and regeneration of tissue damaged by injury and disease. The company currently has programs in three areas: liver cell therapy and progenitor cell therapy as a treatment for liver failure; small molecule catalytic antioxidants as treatment for stroke and tissue damage; and deligioparin (formerly named OP2000), an ultra-low molecular wei...

MOTION PT Holdings, Inc.

MOTION PT Holdings was formed in June 2015 through the combination of Brooklyn-based MetroSportsMed with Manhattan-based STAR Physical Therapy. Today, MOTION has over 180 employees. Headquartered in Brooklyn, New York, with 11 locations, the company is a leading provider of comprehensive physical and occupational therapy services with locations in Brooklyn...

VIRalliance

VIRalliance develops and markets high added value services and products to help optimise drug discovery and patient treatment in the fields of infectious diseases and oncology.VIRalliance has a development portfolio of innovative predictive tests to aid the optimal treatment.PHENOSCRIPT™ is the first of these tests to be made available to the public. PHENOSCRIPT™ is a novel and rapid HIV phen...

Dimension Therapeutics, Inc.

Dimension Therapeutics, Inc. is a gene therapy company focused on developing novel treatments for patients with hemophilia and rare diseases. Dimension has built a product development pipeline based on an industry-leading adeno-associated virus (AAV) platform, and the Company is advancing multiple gene therapy programs toward clinical development. These pr...

American Society of Gene Therapy

The American Society of Gene Therapy (ASGT) is a non-profit medical and professional organization that represents researchers and scientists devoted to the discovery of new gene therapies. ASGT was established in 1996 by Dr. George Stamatoyannopoulos, professor of medicine at the University of Washington 's School of Medicine and a group of the country's leading researchers in gene therapy. With m...

Pharmacyclics Incorporated

Pharmacyclics, Inc. is a pharmaceutical company developing energy-potentiating drugs to improve radiation therapy andchemotherapy of cancer, and to enable or improve the photodynamic therapy of certain cancers, atherosclerotic cardiovascular disease and retinal diseases. The Company's products are ring-shaped small molecules, called "texaphyrins,"which are patented agents derived from Pharmacyclic...

AlphaCore Pharma

AlphaCore Pharma is an Ann Arbor-based private company focused on the development of ACP-501 as a therapy for acute coronary syndromes, and other high-risk atherosclerosis conditions. ACP-501 is recombinant human lecithin: cholesterol acyltransferase (or rhLCAT), an enzyme required for cholesterol metabolism. Additionally, ACP-501 is being developed to tre...

U.S. Physical Therapy, Inc.      

Founded in 1990, U.S. Physical Therapy, Inc. operates 562 outpatient physical therapy clinics in 42 states. The Company's clinics provide preventative and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, treatment for neurologically-related injuries and rehabilitation of injured workers. In addition to owning a...

NightstaRx Limited

Nightstar is a leading retinal gene therapy company focused on developing and commercializing novel, potentially curative one-time treatments for patients suffering from rare inherited retinal diseases that would otherwise progress to blindness, and for which there are no other treatment options. Nightstar’s lead program, NSR-REP1, is being developed ...

Cyto Pulse Sciences, Inc.

Cyto Pulse Sciences, Inc. is a biomedical device and treatment development company creating innovative technology to produce and deliver new therapeutics for cancer (immunotherapy), infectious diseases (prophylaxis therapy), and genetic defects (gene therapy). Cyto Pulse technology is used in a wide range of fields including monoclonal antibody discovery, ...

Avigen

Avigen is a leader in the development of gene therapy products derived from adeno-associated virus ("AAV") for the treatment of inherited diseases. Avigen's proposed gene therapy products are designed for in vivo administration to achieve the production of therapeutic proteins within the body. Avigen has honed it's strategic focus on developing a broad-based proprietary gene delivery technology, A...

Digital Health Corp

Digital Health Corp is a diversified healthcare company that harnesses the power of the latest technology to create personalized and affordable home-based therapy solutions that accelerate and improve patient recovery from surgical intervention, injury, or illness. The company is comprised of businesses across a range of healthcare and wellness therapies, ...

The Alliance for the Advancement of Adult Stem Cell Therapy and Research

The Alliance for the Advancement of Adult Stem Cell Therapy and Research, is a non-profit organization dedicated to promoting the use of adult stem cells in the research and treatment of life-altering diseases. This alliance also strives to ensure treatment for those who qualify and could not otherwise afford to receive it. To become a supporting member, p...

Provident Healthcare Ventures, LLC

Provident Healthcare Ventures, LLC (“Provident”) is a healthcare venture fund comprised of experts in the healthcare industry and members with critical fund management experience. Provident identifies and primarily targets early-stage middle-market healthcare companies, focusing on certain niche healthcare services sectors, including, but not limited ...

Biomed Pharmaceuticals

The Company is a leading pharmacy provider of intravenous and injectable medications for patients with chronic disorders. Biomed treats a variety of immune deficient and autoimmune disorders through Intravenous Immunoglobulin (“IVIG”) therapy, as well as hemophilia and Rheumatoid Arthritis. In addition to filling a patient’s prescriptions, Biomedâ...

NeuroTronik

NeuroTronik was founded in July 2012 to pursue a novel neurostimulation therapy for the enhancement of heart function in the hospital or clinic. The therapy approach was conceived through work at Synecor LLC and Interventional Autonomics Corporation. The Company achieved its Series A Preferred Stock Financing in May 2013, led by Hatteras Venture Partners. ...


More From BioPortfolio on "Therapy With Bevacizumab (BEV), Doxorubicin, and Cyclophosphamide Followed by BEV, Docetaxel, and Capecitabine Before Surgery Followed by BEV Alone After Surgery for Women With Locally Advanced Breast Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks